Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 5, 2013, Pages 414-416

  Johnson, Kevin ^a   Notrica, David M ^a,b,c   Carpentieri, David ^d,e   Jaroszewski, Dawn ^f   Henry, Michael M ^g  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d Department of Pediatrics and Clinical Pathology ^*  (United States)

^e PHOENIX CHILDREN'S HOSPITAL   (United States)

^f MAYO CLINIC   (United States)

^g MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer pharmacology; Celecoxib; Inflammatory myofibroblastic tumor (IMT); Metastasis; Pediatric lung cancer

Indexed keywords

CELECOXIB; DOXORUBICIN; IFOSFAMIDE; VIMENTIN; VINCRISTINE;

ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DRUG FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUCOSA INFLAMMATION; PANCYTOPENIA; PLASMA CELL GRANULOMA; PLEURA METASTASIS; PRIORITY JOURNAL; SCHOOL CHILD; THORACOSCOPY; THORAX RADIOGRAPHY; TREATMENT DURATION; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; PYRAZOLES; SARCOMA; SULFONAMIDES; VINCRISTINE;

EID: 84880266198     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182915cef     Document Type: Article

References (19)

1. Anthony PP. Inflammatory pseudotumor (plasma cell granuloma) of lung, liver and other organs. Histopathology. 1993; 23:501-503.
2. Coffin CM, Watterson J, Priest JR, et al. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859-872.
3. Hoover SV, Granston AS, Koch DF, et al. Plasma cell granuloma of the lung, response to radiation therapy. Cancer. 1976;39:123-125.
4. Hakozaki Y, Katou M, Nakagawa K, et al. Improvement of inflammatory pseudotumor of the liver after nonsteroidal antiinflammatory agent therapy. Am J Gastroenterol. 1993;88: 1121-1122.
5. Berger A, Kim C, Hagstrom N, et al. Successful preoperative treatment of pediatric bladder inflammatory myofibroblastic tumor with anti-inflammatory . Urology. 2007;70:372e13-e15.
6. Mattei P, Barnaby K. Rapid regression of duodenal inflammatory myofibroblastic tumor after intravenous keterolac: case report and review of the literature. J Pediatr Surg. 2008;43: 1196-1199.
7. Xin X, Majumder M, Girish GV, et al. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Lab Invest. 2012. [Epub ahead of print].
8. Pappo AS, Devidas M, Jenkins J, et al. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol. 2005;23:4031-4038.
9. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggresive cases. Am J Surg Pathol. 2007;31: 509-520.
10. Donner LR, Trompler RA, White RR. Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) or soft tissue into sarcoma after several recurrences. Hum Pathol. 1996;27:1095-1098.
11. Sanders BM, West KW, Gingalewski C, et al. Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience. J Pediatr Surg. 2001;36:169-173.
12. Dishop MK, Warner BW, Dehner LP, et al. Successful treatment of inflammatory myofibroblastic tumor with malignant transformation by surgical resection and chemotherapy. J Pediatr Hematol Oncol. 2002;25:153-158.
13. Janik JS, Janik JP, Lovell MA, et al. Recurrent inflammatory pseudotumors in children. J Pediatr Surg. 2003;38:1491-1495.
14. Snyder CS, Dell'Aquila M, Haghighi P, et al. Clonal changes in inflammatory pseudotumor of the lung. Cancer. 1995;76: 1545-1549.
15. Biselli R, Ferlini C, Fattorossi A, et al. Inflammatory myofibroblastic tumor (inflammatory pseudotumor). DNA flow cytometric analysis of nine pediatric cases. Cancer. 1996;77:778-784.
16. Butrynski JE, D'Adamo DR, Hornick JL, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363:1727-1733.
17. Vassiliadis T, Vougiouklis N, Patsiaoura K, et al. Inflammatory pseudotumor of the liver successfully treated with nonsteroidal anti-inflammatory drugs: a challenge diagnosis for one not so rare entity. Eur J Gastroenterol and Hepatol. 2007;19:1016-1020.
18. Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 2000;60:1306-1311.
19. Applebaum H, Kieran MW, Cripe TP, et al. The rationale for nonsteriodal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study. J Pediatr Surg. 2005;40:999-1003.